The differences and why they matter for investors


Johnson and Johnson hygiene products for sale in a supermarket in Madrid, Spain.

Cristina Arias | Cover | Getty Images

Johnson & Johnson (JNJ) — an iconic, 136-year-old American enterprise — will soon reshape itself, separating its division that makes Tylenol, Band-Aids, and other consumer health products into a standalone public company. The Club holding’s upcoming transaction highlights an advantageous tool that management teams can use to boost shareholder value: divestitures.

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top